tiprankstipranks
Avidity Biosciences Inc (RNA)
NASDAQ:RNA
US Market

Avidity Biosciences (RNA) Income Statement

Compare
751 Followers

Avidity Biosciences Income Statement

Last quarter (Q3 2024), Avidity Biosciences's total revenue was $2.34M, a decrease of -17.10% from the same quarter last year. In Q3, Avidity Biosciences's net income was $-80.40M. See Avidity Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 9.56M$ 9.22M$ 9.33M$ 6.79M$ 2.32M
Gross Profit
$ 7.46M$ 7.84M$ 8.69M$ -30.82M$ -12.22M
Operating Expenses
$ 245.16M$ 188.14M$ 127.38M$ 51.06M$ 19.65M
Depreciation and Amortization
$ 2.10M$ 1.39M$ 639.00K$ 373.00K$ 597.00K
EBITDA
$ -233.50M$ -177.53M$ -117.41M$ -43.77M$ -16.75M
Operating Income
$ -235.60M$ -178.91M$ -118.05M$ -44.28M$ -17.33M
Other Income/Expenses
$ 23.38M$ 4.92M$ 42.00K$ -78.00K$ -7.40M
Pretax Income
$ -212.22M$ -174.00M$ -118.01M$ -44.35M$ -24.73M
Net Income
$ -212.22M$ -169.08M$ -117.37M$ -43.98M$ -32.12M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.91$ -3.24$ -2.83$ -2.03$ -0.86
Diluted EPS
$ -2.91$ -3.24$ -2.83$ -2.03$ -0.86
Weighted Average Shares Outstanding
73.01M 52.16M 41.43M 21.66M 37.51M
Weighted Average Shares Outstanding (Diluted)
73.01M 52.16M 41.43M 21.66M 37.51M
Currency in USD

Avidity Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis